FDA allows testing of Aethlon device in Ebola patients
Aethlon Medical Inc. said the U.S. Food and Drug Administration had approved the testing in Ebola patients of its bio-filtration device, which was used against the deadly virus in a critically ill patient in Germany who later recovered. The device, being developed as a broad-spectrum countermeasure against pandemic threats, filters viruses and toxins from the blood.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063